TCI Wealth Advisors’s Astrana Health ASTH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
Sell
-1
Closed -$37 2313
2023
Q1
$37 Buy
+1
New +$35 ﹤0.01% 2460
2022
Q4
Sell
-111
Closed -$4K 2671
2022
Q3
$4K Buy
111
+1
+0.9% +$46 ﹤0.01% 1702
2022
Q2
$4K Buy
+110
New +$4.18K ﹤0.01% 1722
2022
Q1
Sell
-96
Closed -$7K 2494
2021
Q4
$7K Buy
96
+57
+146% +$4.68K ﹤0.01% 1474
2021
Q3
$4K Buy
+39
New +$3.32K ﹤0.01% 1844

Other funds holding ASTH

TCI Wealth Advisors's ASTH Position: Q2 2023 in Review

TCI Wealth Advisors sold out of Astrana Health (ASTH) in Q2 2023, closing a stake of 1 share — an estimated $37 sold.

TCI Wealth Advisors first reported a position in ASTH in Q3 2021 and held it in 5 quarters. The position peaked at $7K in Q4 2021. 130 funds tracked by Wall St. Rank hold ASTH as of Q2 2023.

  • TCI Wealth Advisors reported no remaining Astrana Health position as of Q2 2023 after selling out during the quarter.
  • TCI Wealth Advisors sold 1 Astrana Health share in Q2 2023, an estimated $37.
  • TCI Wealth Advisors first reported a position in Astrana Health in Q3 2021 and held it in 5 quarters.
  • TCI Wealth Advisors's Astrana Health position peaked at $7K in Q4 2021.
  • 130 funds tracked by Wall St. Rank held Astrana Health as of Q2 2023.

Based on TCI Wealth Advisors's 13F filing for Q2 2023, filed 4 Aug 2023.